The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019,…
Read More
The American Thyroid Association will hold its 89th Annual Meeting on October 30-November 3, 2019,…
October 2, 2018—The American Thyroid Association (ATA) will hold its 88th Annual Meeting on October…
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for…
DIAGNOSED AND TREATED FOR THYROID CANCER? ATA® INVITES YOUR FEEDBACK ON THIS SURVEY: https://www.surveymonkey.com/r/thyroidcancerpatientsurvey The…
New Rochelle, NY, December 14, 2017—A 10-year study of more than 1,200 patients with low-risk…
Supported by ThyCa: Thyroid Cancer Survivors’ Association, Inc. and ATA Nikita Pozdeyev, M.D., Ph.D. is…